Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2025-10-22
2047-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Major Depressive Disorder (MDD) will be assessed using a validated tool: the Composite International Diagnostic Interview Short-Form (CIDI-SF).
1. Measure the annual prevalence of psychiatric disorders other than depression (anxiety, burnout, eating disorders, alcohol and cannabis addiction, childhood trauma) among medical students by comparing them to students who completed their first year but did not enter the medical program.
2. Identify risk and protective factors for psychiatric disorders other than depression (anxiety, burnout, eating disorders, alcohol and cannabis addiction) among medical students by comparing them to students who completed their first year but did not enter the medical program.
For these two objectives, anxiety will be assessed using the GAD7; eating disorders by the SCOFF, alcohol addiction by the AUDIT, cannabis addiction by the CUDIT, burnout by the MBI-SS (student version for pre-clinical students) or the MBI-HSS (caregiver version for externs and residents), and childhood trauma by the ACE.
3. Measure the prevalence of MDD each year among medical students by comparing them to students who have completed their first year but have not entered the medical program.
4. Measure the prevalence of healthcare use and non-use among medical students each year by comparing them to students who completed their first year but did not enter the medical program.
5. Identify risk factors for non-use of healthcare among medical students by comparing them to students who completed their first year but did not enter the medical program.
6. Assess the stigma associated with psychiatric disorders or the discipline of psychiatry among medical students by comparing them to students who completed their first year but did not enter the medical program.
7. Study the factors of financial and social insecurity (several variables) among medical students by comparing them to students who completed their first year but did not enter the medical program.
8. For postgraduate students, assess their feelings about educational support. This a prospective, longitudinal, cohort study. The plan is to inform each new cohort of students at the Orléans University Hospital medical school for 10 years. It is estimated that 5,000 to 10,000 students will be able to participate in the study.
A link to access the study questionnaire will be sent to students by email via the registrar's office, with one email per week for four weeks. The email will contain a link to a web page where the questionnaire can be completed. The questionnaire will be available online on computers or smartphones for six weeks: from mid-October to the end of November. The questionnaire will be completed each year for the duration of the study or until the student completes their studies.
Duration of the inclusion period: 10 years Duration of participation for each participant: maximum 12 years Total duration of the study: 22 years As the cohort progresses, longitudinal analyses may be conducted to study the evolution of various disorders over time, adjusting for known confounding factors. Following the initial analyses of this study, a new interventional study will be set up to identify students at risk and offer them appropriate care.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Major Depressive Disorder (MDD) will be assessed using a validated tool: the Composite International Diagnostic Interview Short-Form (CIDI-SF).
1. Measure the annual prevalence of psychiatric disorders other than depression (anxiety, burnout, eating disorders, alcohol and cannabis addiction, childhood trauma) among medical students by comparing them to students who completed their first year but did not enter the medical program.
2. Identify risk and protective factors for psychiatric disorders other than depression (anxiety, burnout, eating disorders, alcohol and cannabis addiction) among medical students by comparing them to students who completed their first year but did not enter the medical program.
For these two objectives, anxiety will be assessed using the GAD7; eating disorders by the SCOFF, alcohol addiction by the AUDIT, cannabis addiction by the CUDIT, burnout by the MBI-SS (student version for pre-clinical students) or the MBI-HSS (caregiver version for externs and residents), and childhood trauma by the ACE.
3. Measure the prevalence of MDD each year among medical students by comparing them to students who have completed their first year but have not entered the medical program.
4. Measure the prevalence of healthcare use and non-use among medical students each year by comparing them to students who completed their first year but did not enter the medical program.
5. Identify risk factors for non-use of healthcare among medical students by comparing them to students who completed their first year but did not enter the medical program.
6. Assess the stigma associated with psychiatric disorders or the discipline of psychiatry among medical students by comparing them to students who completed their first year but did not enter the medical program.
7. Study the factors of financial and social insecurity (several variables) among medical students by comparing them to students who completed their first year but did not enter the medical program.
8. For postgraduate students, assess their feelings about educational support. This a prospective, longitudinal, cohort study. The plan is to inform each new cohort of students at the Orléans University Hospital medical school for 10 years. It is estimated that 5,000 to 10,000 students will be able to participate in the study.
List of main inclusion criteria
1. Students who have been enrolled in first year of health studies at the University of Orléans
2. Aged 18 or over List of main exclusion criteria
1\. Does not speak French 2. Person under legal guardianship 3. Person deprived of liberty 4. Persons under guardianship or trusteeship Medical students will be informed of the protocol at meetings at the University of Orléans at the start of the academic year in September each year. The study will be offered each year to students entering PASS/LAS at the Faculty of Medicine of the University of Orléans and to cohorts that have already begun their medical studies.
A link to access the study questionnaire will be sent to students by email via the registrar's office, with one email per week for four weeks. The email will contain a link to a Callyope web page where the questionnaire can be completed. Students will create an account using their university email address as their username. The questionnaire will be available online on computers or smartphones for six weeks: from mid-October to the end of November. The questionnaire will be completed each year between mid-October and the end of November for the duration of the study or until the student completes their studies.
Duration of the inclusion period: 10 years Duration of participation for each participant: maximum 12 years Total duration of the study: 22 years As the cohort progresses, longitudinal analyses may be conducted to study the evolution of various disorders over time, adjusting for known confounding factors. Following the initial analyses of this study, a new interventional study will be set up to identify students at risk and offer them appropriate care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medical students
Medical students: students who succeed to integrate medical school after the selection at the end of the first year of health studies.
Questionnaire
Questionnaire to be completed once a year
Non medical students
Non medical students: students who fail to integrate medical school after the selection at the end of the first year of health studies.
Questionnaire
Questionnaire to be completed once a year
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Questionnaire to be completed once a year
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 or over
Exclusion Criteria
* Person under legal guardianship
* Person deprived of liberty
* Person under guardianship or trusteeship
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional d'Orléans
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jasmina MALLET, MD-PhD
Role: PRINCIPAL_INVESTIGATOR
CHOrléans
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire d'Orléans
Orléans, Loiret, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jasmina MALLET, MD-PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.
Garcia FD, Grigioni S, Chelali S, Meyrignac G, Thibaut F, Dechelotte P. Validation of the French version of SCOFF questionnaire for screening of eating disorders among adults. World J Biol Psychiatry. 2010 Oct;11(7):888-93. doi: 10.3109/15622975.2010.483251.
Gache P, Michaud P, Landry U, Accietto C, Arfaoui S, Wenger O, Daeppen JB. The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res. 2005 Nov;29(11):2001-7. doi: 10.1097/01.alc.0000187034.58955.64.
Luquiens A, Berger-Viergat A, Larrieu A, Artigaud L, Fener C, Adamson S, Laprevote V, Rolland B. Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample. Drug Alcohol Rev. 2021 Nov;40(7):1334-1339. doi: 10.1111/dar.13298. Epub 2021 Apr 14.
Simon N, Verdoux H. [Impact of education program and clinical posting in psychiatry on medical students' stigmatizing attitudes towards psychiatry and psychiatric disorders]. Encephale. 2018 Sep;44(4):329-336. doi: 10.1016/j.encep.2017.05.003. Epub 2017 Jun 9. French.
Husky MM, Leon C, du Roscoat E, Vasiliadis HM. Prevalence of suicidal thoughts and behaviors among young adults between 2000 and 2021: Results from six national representative surveys in France. Psychiatry Res. 2024 Mar;333:115763. doi: 10.1016/j.psychres.2024.115763. Epub 2024 Feb 1.
Frajerman A, Chevance A, Chaumette B, Morvan Y. Prevalence and factors associated with depression and suicidal ideation among French students in 2016: A national study. Psychiatry Res. 2023 Aug;326:115263. doi: 10.1016/j.psychres.2023.115263. Epub 2023 May 30.
Frajerman A, Rolland F, Hadouiri N, Haas-Jordache A, Gouy E, Mathieu L, Goulard A, Leon C, Morvan Y. Depression and suicidal thoughts in medical students and the general population: A comparison from 2 national studies. Gen Hosp Psychiatry. 2024 Sep-Oct;90:204-205. doi: 10.1016/j.genhosppsych.2024.07.002. Epub 2024 Jul 4. No abstract available.
Rolland F, Hadouiri N, Haas-Jordache A, Gouy E, Mathieu L, Goulard A, Morvan Y, Frajerman A. Mental health and working conditions among French medical students: A nationwide study. J Affect Disord. 2022 Jun 1;306:124-130. doi: 10.1016/j.jad.2022.03.001. Epub 2022 Mar 8.
Vergeron L, Morvan Y, Hadouiri N, Haas-Jordache A, Gouy E, Mathieu L, Goulard A, Rolland F, Frajerman A. Use of service and treatment adequacy in medical students and residents suffering from depression in France: A nationwide study. Psychiatry Res. 2024 Sep;339:115975. doi: 10.1016/j.psychres.2024.115975. Epub 2024 May 31.
Frajerman A. [Which interventions improve the well-being of medical students? A review of the literature]. Encephale. 2020 Feb;46(1):55-64. doi: 10.1016/j.encep.2019.09.004. Epub 2019 Nov 22. French.
Gosling CJ, Colle R, Cartigny A, Jollant F, Corruble E, Frajerman A. Measuring loneliness: a head-to-head psychometric comparison of the 3- and 20-item UCLA Loneliness Scales. Psychol Med. 2024 Oct 31;54(14):1-7. doi: 10.1017/S0033291724002083. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUO-2025-10
Identifier Type: -
Identifier Source: org_study_id